Tepha

Tepha Inc., founded in 1998 and headquartered in Lexington, MA, is a supplier of medical devices focused on its proprietary P4HB polymer technology. Tepha's products are designed and developed to elevate, support and reinforce soft tissue as well as to stimulate tissue healing and regenerative processes. Commercial mesh and suture products based on Tepha's resorbable P4HB polymer technology are currently utilized in the fields of hernia repair, orthopedic soft tissue repair, general wound repair, and plastic and reconstructive surgery through Tepha's wholly owned subsidiary, Galatea Inc. Tepha and its partners have received 29 FDA 510(k) and 8 CE Mark clearances in the United States in Europe, respectively. To date, products made from P4HB have been successfully used in more than 4,000,000 surgical procedures worldwide, and have been the subject of over 60 published clinical and scientific papers.